Detalhe da pesquisa
1.
Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
Gut
; 72(11): 2031-2038, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468228
2.
The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making.
Dig Dis
; 41(6): 879-889, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611561
3.
Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg).
Gut
; 2022 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36591610
4.
Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study.
Gastroenterol Hepatol
; 45(3): 165-176, 2022 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-34051313
5.
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg).
Helicobacter
; 25(5): e12722, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32656898
6.
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg).
Helicobacter
; 25(3): e12686, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173974
7.
Endoscopic progression of ulcerative proctitis to proximal disease. Can we identify predictors of progression?
Scand J Gastroenterol
; 53(10-11): 1286-1290, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30351984
8.
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
Aliment Pharmacol Ther
; 59(10): 1248-1259, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445785
9.
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU.
Therap Adv Gastroenterol
; 17: 17562848241234476, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445247
10.
Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review.
J Clin Med
; 12(23)2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38068418
11.
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study.
Aliment Pharmacol Ther
; 58(1): 60-70, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37089065
12.
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP.
J Clin Med
; 12(14)2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37510928
13.
Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021.
World J Gastroenterol
; 28(5): 502-516, 2022 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316962
14.
Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia.
J Clin Med
; 11(10)2022 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628914
15.
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885.
J Clin Med
; 11(19)2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233844
16.
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).
J Clin Med
; 11(24)2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36556155
17.
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry.
J Clin Med
; 11(2)2022 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35054116
18.
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.
J Clin Med
; 11(15)2022 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35956133
19.
Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease.
World J Clin Cases
; 9(36): 11285-11299, 2021 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35071559
20.
Impact of BMGIM Music Therapy on Emotional State in Patients with Inflammatory Bowel Disease: A Randomized Controlled Trial.
J Clin Med
; 10(8)2021 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33918724